Mycophenolate mofetil for myasthenia gravis: A double-blind, placebo-controlled pilot study

Annals of the New York Academy of Sciences

Volumn 998, Issue , 2003, Pages 494-499

  Meriggioli, Matthew N ^a,b   Rowin, Julie ^a   Richman, Judith G ^a   Leurgans, Sue ^a  

^a RUSH UNIVERSITY   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

Myasthenia gravis; Mycophenolate mofetil; Quantitative myasthenia gravis score

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INSOMNIA; MALE; MYASTHENIA GRAVIS; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; URINARY TRACT INFECTION;

EID: 0141615801     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1254.064     Document Type: Conference Paper

References (7)

1. CHAUDHRY, V., D.R. CORNBLATH, J.W. GRIFFIN et al. 2001. Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology 56: 94-96.
2. CIAFALONI, E., J.M. MASSEY, B. TUCKER-LIPSCOMB & D.B. SANDERS. 2001. Mycophenolate mofetil for myasthenia gravis: an open-label pilot study. Neurology 56: 97-99.
3. COS, L., A.K. MANKODI, R. TAWIL & C.A. THORNTON. 2000. Neurology 54(suppl. 3): AI37.
4. JARETZKI, A., R.J. BAROHN, R.M. ERNSTOFF et al. 2000. Myasthenia gravis: recommendations for clinical research standards. Neurology 55: 16-23.
5. BAROHN, R.J., D. MCINTIRE, L. HERBELIN et al. 1998. Reliability testing of the quantitative myasthenia gravis score. Ann. N.Y. Acad. Sci. 841: 769-772.
6. SANDERS, D.B., B. TUCKER-LIPSCOMB & J.M. MASSEY. 2003. A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score. This volume.
7. MOURAD, M., P. WALLEMACQ, J. KONIG et al. 2002. Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary? Clin. Pharmacokinet. 41: 319-327.